Finance

Lists
Q3 2026 earnings • released • EPS beat +284.30% • Revenue beat +0.14%
See results
WGS:NASDAQ
GeneDx Holdings Corp
$52.37
+0.96%
(+0.50) 1D
$52.02
-0.67% (-0.35)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WGS...
Open
$51.01
High
$52.59
Low
$48.42
Mkt. cap
1.57B
Avg. vol.
955.90K
Volume
1.12M
52-wk high
$170.87
52-wk low
$32.21
EPS
-$3.63
Beta
2.00
Shares outstanding
29.97M
No. of employees
1K
Open
$51.01
High
$52.59
Low
$48.42
Mkt. cap
1.57B
Avg. vol.
955.90K
Volume
1.12M
52-wk high
$170.87
52-wk low
$32.21
EPS
-$3.63
Beta
2.00
Shares outstanding
29.97M
No. of employees
1K
News stories
From web sources and news partners
About GeneDx Holdings Corp
CEO-
Employees1.3K
Founded2000
HeadquartersStamford, Connecticut, United States
SectorHealth Care
IndustryHealth care provider
Websitegenedx.com
Analyst ratings
Based on 5 analysts giving stock ratings to WGS in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for WGS in the last 3 months.
Highest
Current $52.37
$95.00 (+81.40%)
Average
$83.80 (+60.02%)
Lowest
$66.00 (+26.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Bonello
Craig-Hallum
Buy
Maintained
$66.00
+26%
11/13/2026
David Westenberg
Piper Sandler
Buy
Maintained
$95.00
+81.4%
11/10/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
$83.00
+58.5%
11/09/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$90.00
+71.9%
11/10/2026
Mark Massaro
BTIG
Buy
Reiterated
$85.00
+62.3%
11/09/2026
Keith Hinton
Freedom Capital Markets
Buy
Reiterated
$102.00
+94.8%
08/11/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
$75.00
+43.2%
08/04/2026
Daniel Brennan
TD Cowen
Buy
Maintained
$85.00
+62.3%
07/15/2026
Tycho Peterson
Jefferies
Buy
Maintained
$100.00
+90.9%
05/27/2026
John Wilkin
Craig-Hallum
Buy
Reiterated
$85.00
+62.3%
05/05/2026
Last report
Nov 9, 2026
Fiscal period
Q3 2026
$0.28 / $0.07
+284.30%beat
Revenue / Est. (USD)
123.10M / 122.92M
+0.14%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
120.99M
102.25M
114.44M
123.10M
Cost of goods sold
36.72M
34.04M
36.16M
37.02M
Cost of revenue
36.72M
34.04M
36.16M
37.02M
Research and development expenses
24.54M
19.80M
19.66M
17.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
72.56M
74.59M
76.04M
78.22M
Operating expense
97.10M
94.40M
95.69M
95.64M
Total operating expenses
133.82M
128.44M
131.85M
132.66M
Operating income
-12.83M
-26.18M
-17.41M
-9.56M
Other non operating income
-2.56M
2.33M
382.00K
-94.00K
EBT including unusual items
-18.23M
-62.42M
-18.26M
-12.30M
EBT excluding unusual items
-15.91M
-24.57M
-18.21M
-11.43M
Income tax expense
-564.00K
897.00K
-518.00K
26.00K
Effective tax rate
3.09%
-1.44%
2.84%
-0.21%
Other operating expenses
-
-
-
-
Net income
-17.67M
-63.32M
-17.74M
-12.33M
Net profit margin
-14.60%
-61.92%
-15.50%
-10.01%
Earnings per share
0.14
-0.28
0.01
0.28
Interest and investment income
-
-
-
-
Interest expense
-520.00K
-717.00K
-1.18M
-1.78M
Net interest expenses
-520.00K
-717.00K
-1.18M
-1.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.85M
-19.38M
-10.69M
-2.67M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps